Frontiers In Immunology

dc.creatorArellano-Lorca, Gabriel
dc.creatorOttum, Payton A
dc.creatorReyes, Lilian I
dc.creatorBurgos, Paula Isabel
dc.creatorNaves-Pichuante, Rodrigo Antonio
dc.date2018-10-02T18:15:06Z
dc.date2022-07-07T15:19:33Z
dc.date2018-10-02T18:15:06Z
dc.date2022-07-07T15:19:33Z
dc.date2015
dc.date.accessioned2023-08-22T01:32:46Z
dc.date.available2023-08-22T01:32:46Z
dc.identifier1140049
dc.identifier1140049
dc.identifierhttps://hdl.handle.net/10533/220770
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8306407
dc.descriptionThe role of interferon (IFN)-gamma in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), has remained as an enigmatic paradox for more than 30 years. Several studies attribute this cytokine a prominent proinflammatory and pathogenic function in these pathologies. However, accumulating evidence shows that IFN-gamma also plays a protective role inducing regulatory cell activity and modulating the effector T cell response. Several innate and adaptive immune cells also develop opposite functions strongly associated with the production of IFN-gamma in EAE. Even the suppressive activity of different types of regulatory cells is dependent on IFN-gamma Interestingly, recent data supports a stage-specific participation of IFN-gamma in EAE providing a plausible explanation for previous conflicting results. In this review, we will summarize and discuss such literature, emphasizing the protective role of IFN-gamma on immune cells. These findings are fundamental to understand the complex role of IFN-gamma in the pathogenesis of these diseases and can provide basis for potential stage-specific therapy for MS targeting IFN-gamma-signaling or IFN-gamma producing immune cells. Keywords. Author Keywords:interferon-gamma; experimental autoimmune encephalomyelitis; multiple sclerosis; innate immunity; adaptive immunity; neuroinflammation . KeyWords Plus:EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NATURAL-KILLER-CELLS; DELTA T-CELLS; MONOCLONAL-ANTIBODY TREATMENT; INVARIANT NKT CELLS; IFN-GAMMA; REGULATORY ROLE; NITRIC-OXIDE; TNF-ALPHA
dc.languageeng
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinfo:eu-repo/grantAgreement//1140049
dc.relationinfo:eu-repo/semantics/dataset/hdl.handle.net/10533/93477
dc.relationhttps://www.ncbi.nlm.nih.gov/pubmed/26483787
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.titleStage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis
dc.titleFrontiers In Immunology
dc.typeArticulo
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución